Cleveland Clinic Researchers Find iPad A Powerful Multiple Sclerosis Assessment Tool
Tracking patients’ progress is a critical part of MS management, a process that can benefit from greater objective analysis. Researchers…
Articles by Charles Moore
Increased R&D Focus On PoNS Neuromodulation Therapy Device For People With MS; Other Neurological Conditions
Newtown, Pennsylvania based Helius Medical Technologies, Inc. announced on June 6th that the company has entered into an agreement…
Can Low Carb, High Fat Ketogenic Diets Improve MS And Other Neurological Disease Symptoms?
Dr. Terry Wahls, a clinical professor of medicine at the University of Iowa Carver College of Medicine in Iowa…
Natalizumab, Other Biogen Idec MS Therapies Featured at Medical Congresses; Company Joins Sailing Sclerosis Foundation Oceans of Hope Project
Biogen Idec, a U.S. biotechnology company specializing in therapies for neurological disorders, autoimmune disorders and cancer, has announced…
Researchers Report Alternate Explanation Discovery Of How And Why CCSVI Treatment Works In MS Patients
A new study may offer new insight on beneficial effects of “chronic cerebrospinal venous insufficiency” (CCSVI or CCVI) treatment…
Better MS Tracking Tool Developed by Robarts Institute Scientists At University of Western Ontario
A team of magnetic imaging scientists led by Dr. Ravi Menon, PhD, at the University of Western Ontario’s…
Another Canadian Study Finds No Link Between Blocked Neck Veins And MS
Another study, in what has become a succession of Canadian studies, has failed to detect a link between blocked…
Genzyme Resubmits Multiple Sclerosis Drug Lemtrada For FDA sBLA Approval Review
Cambridge, Mass. Based Genzyme, a Sanofi subsidiary, announced May 30 that the U.S. Food and Drug Administration (FDA) has…
Is Vitamin D Supplementation Effective For Fighting Multiple Sclerosis, Fibromyalgia, and Parkinson’s?
Sturgeon Bay, Wisconsin chiropractor, naturopath and health blogger Dr. J.G. Moellendorf, DC, ND, LCP notes that while its been…
Study Finds MS Drug Gilenya May Point To Development Of New PTSD Therapy
A new study on mice published in Nature Neuroscience finds that fingolimod (Novartis brand name Gilenya) a first-in-class…
MRI Spectroscopy May Improve Accuracy in Predicting MS Progression
A new study published this week in the Journal of the American Medical Association Neurology says that predicting disease…
Hematopoietic Stem Cell Transplantation: MS Breakthrough Treatment Or Another “Liberation Therapy” Disappointment Shaping Up?
Multiple Sclerosis (MS) is a devastating disease for many who become afflicted with the disease’s progressive form, often in…
Researchers Report Encouraging Results in Mouse Model MS Stem Cell Therapy Research
Scientists at the Scripps Research Institute (TSRI), the University of California (UC), Irvine and The University of…
Genzyme Enters Multi-Year MS Research Collaboration with Cleveland Clinic’s Academic Medical Center
Cambridge, Massachusetts based biotech firm Genzyme has formed a new research collaboration with Cleveland Clinic of Cleveland, Ohio…
MS, Other Autoimmune Diseases, May Be Vulnerable To New Drug Strategy Identified In UCSF/Harvard Genome Study
New classes of pharmaceutical agents tailored to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be…
Debate Over Medical Marijuana For MS And Other Diseases Heats Up
Steve Pepple / Shutterstock.com The 2012 state ballot approvals of marijuana legalization in Colorado and Washington has…
Supreme Court Denies Injunction Request To Block Release Of Generic MS Drug, But Patent Fight Not Over Yet
Petah Tikvah Israel-based Teva Pharmaceutical Industries Ltd. has suffered a setback in its fight to forestall release of generic competitors…